DurgicalDurgical
EN
Open the app

Interleukin-1 !

  • Molecule

IL-1 is an alarm cytokine made by macrophages: it causes fever and inflammation, and its excess drives rare inherited fever syndromes.

Updated 2026-11-01

What it is

Interleukin-1 is a family of cytokines; the two classic members are IL-1α and IL-1β, which share one signalling receptor (IL-1R1). IL-1β is made as an inactive precursor that must be cut by caspase-1, activated inside a protein complex called the inflammasome (NLRP3 is the best known). It is a central driver of fever and acute inflammation, and blocking it controls autoinflammatory diseases.

Structure

  • IL-1α: often stays inside or on the cell and acts as an alarm signal released by damaged cells.
  • IL-1β: secreted after caspase-1 cleaves its precursor (pro-IL-1β).
  • Receptor: IL-1R1, which signals through MyD88, IRAK and TRAF6 to switch on NF-κB.

Function

  • Raises the hypothalamic set point (fever).
  • Activates endothelium so leukocytes can stick and leave the vessel.
  • Induces other cytokines (IL-6, chemokines such as IL-8) and matrix-degrading enzymes.
  • Contributes to systemic inflammation in sepsis.

Clinical notes

  • Cryopyrin-associated periodic syndromes (gain of function of NLRP3): fever, urticaria-like rash, joint pain; treated with IL-1 blockers.
  • Familial Mediterranean fever: IL-1 blockade is an option when colchicine fails or is not tolerated.
  • Gout: urate crystals activate the inflammasome; canakinumab is approved for difficult flares.
  • Still disease and systemic juvenile idiopathic arthritis: IL-1 blockers are used; macrophage activation syndrome is a feared complication.
  • IL-1 blockers raise the risk of infections; latent tuberculosis is screened for before canakinumab.

Test yourself

Think of the answer, then tap the question to see it.

Which enzyme converts pro-IL-1β to its active form?

Caspase-1, activated inside the inflammasome (for example NLRP3).

What is anakinra?

A recombinant form of the natural IL-1 receptor antagonist; it competes with IL-1α and IL-1β for IL-1R1.

Which group of diseases shows the best response to IL-1 blockade?

Autoinflammatory diseases such as cryopyrin-associated periodic syndromes, FMF, TRAPS and mevalonate kinase deficiency.

Add to my cards (3)

In Pharmacology

← All of immunology

Educational content on the immune system; not a treatment or individual vaccination guide and no substitute for a health professional's advice. No doses are given.

Sources: Targeting IL-1β in the Treatment of Atherosclerosis (Frontiers in Immunology, 2020); Pro-Inflammatory and Anti-Inflammatory Interleukins in Infectious Diseases: A Comprehensive Review (Tropical Medicine and Infectious Disease (PubMed Central), 2024); Canakinumab Injection: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2025); Rilonacept Injection: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2025).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.